These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2451415)

  • 1. Noninvasive evaluation of indecainide for serious ventricular tachyarrhythmia.
    Podrid PJ; Hohnloser S; Lown B
    Am J Cardiol; 1988 Apr; 61(10):764-9. PubMed ID: 2451415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic and hemodynamic evaluation of indecainide and procainamide in nonsustained ventricular tachycardia.
    Pratt CM; Francis MJ; Seals AA; Zoghbi W; Young JB
    Am J Cardiol; 1990 Jul; 66(1):68-74. PubMed ID: 2193498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propafenone: noninvasive evaluation of efficacy.
    Podrid PJ; Cytryn R; Lown B
    Am J Cardiol; 1984 Nov; 54(9):53D-59D. PubMed ID: 6496369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effects of oral indecainide in patients with ventricular tachyarrhythmias.
    Macina G; Turitto G; Stavens C; Fontaine J; Hariman R; Ursell S; el-Sherif N
    Clin Cardiol; 1987 Jun; 10(6):357-61. PubMed ID: 3594958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of indecainide in patients with left ventricular dysfunction.
    Giardina EV; Saroff AL; Schneider M
    Clin Pharmacol Ther; 1990 Nov; 48(5):582-9. PubMed ID: 2225716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indecainide compared with quinidine for chronic stable ventricular arrhythmias secondary to coronary artery disease or to cardiomyopathy.
    Giardina EG; Zaim S; Saroff AL; Kirschenbaum M
    Am J Cardiol; 1987 Sep; 60(7):584-9. PubMed ID: 2442993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation.
    Stanton MS; Prystowsky EN; Fineberg NS; Miles WM; Zipes DP; Heger JJ
    J Am Coll Cardiol; 1989 Jul; 14(1):209-15; discussion 216-7. PubMed ID: 2738263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effects of indecainide in a drug-resistant population with ventricular tachycardia at programmed electrical stimulation.
    Miura DS; Wynn J; Keefe D; Laux B; Somberg JC
    Am Heart J; 1987 Jan; 113(1):65-9. PubMed ID: 3799443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure.
    Brodsky MA; Allen BJ; Abate D; Henry WL
    Am Heart J; 1985 Oct; 110(4):794-9. PubMed ID: 4050651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encainide for refractory ventricular tachyarrhythmia.
    Chesnie B; Podrid P; Lown B; Raeder E
    Am J Cardiol; 1983 Sep; 52(5):495-500. PubMed ID: 6193701
    [No Abstract]   [Full Text] [Related]  

  • 11. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
    J Am Coll Cardiol; 1985 Sep; 6(3):539-44. PubMed ID: 2411776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors.
    Podrid PJ; Lampert S; Graboys TB; Blatt CM; Lown B
    Am J Cardiol; 1987 Apr; 59(11):38E-44E. PubMed ID: 2437788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of encainide for malignant ventricular arrhythmias.
    Tordjman T; Podrid PJ; Raeder E; Lown B
    Am J Cardiol; 1986 Aug; 58(5):87C-95C. PubMed ID: 3092625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmia.
    Hirsowitz G; Podrid PJ; Lampert S; Stein J; Lown B
    Am Heart J; 1986 May; 111(5):852-60. PubMed ID: 2871739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lorcainide in patients with refractory ventricular tachyarrhythmia.
    Chesnie B; Lampert S; Podrid P; Lown B
    J Am Coll Cardiol; 1984 Jun; 3(6):1531-9. PubMed ID: 6715710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia.
    Mitchell LB; Duff HJ; Manyari DE; Wyse DG
    N Engl J Med; 1987 Dec; 317(27):1681-7. PubMed ID: 3320747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
    Hession MJ; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical electrophysiology of intravenous indecainide.
    Horowitz LN; Spielman SR; Webb CR; Morganroth J; Greenspan AM
    Am Heart J; 1985 Oct; 110(4):784-8. PubMed ID: 4050649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.